MSB 7.69% $1.19 mesoblast limited

Ann: Mesoblast Phase 3 CLBP Trial Completes Enrollment, page-183

  1. 116 Posts.
    lightbulb Created with Sketch. 12
    Ill probably get shot down for downramping here but this is the one indication im not overly confident on.

    I work as a physio and the so much of the current evidence coming out now in regards to CLBP is that its poorly correlated with actual tissue damage. The cells might repair discs but Im not entirely confident of it addressing pain significantly more than a placebo.

    Would be really happy to be proven wrong and would love someone to explain why I might be incorrect.

    Im really bullish on this stock otherwise and if im proven wrong with CLBP it will be a nice little bonus!

    Last edited by Yarnos20: 05/12/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.